| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 21.21B | 18.91B | 16.49B | 13.52B | 11.22B |
| Gross Profit | 5.92B | 4.22B | 3.62B | 2.69B | 2.14B |
| EBITDA | 6.14B | 3.48B | 3.74B | 1.25B | 996.00M |
| Net Income | 5.84B | 2.52B | 2.41B | -1.27B | 120.00M |
Balance Sheet | |||||
| Total Assets | 38.12B | 35.69B | 31.51B | 29.45B | 28.67B |
| Cash, Cash Equivalents and Short-Term Investments | 6.53B | 5.36B | 3.52B | 2.40B | 2.55B |
| Total Debt | 5.35B | 5.13B | 5.76B | 5.96B | 7.78B |
| Total Liabilities | 35.15B | 36.57B | 35.14B | 35.47B | 33.31B |
| Stockholders Equity | 2.73B | -912.00M | -3.68B | -6.05B | -4.66B |
Cash Flow | |||||
| Free Cash Flow | 3.76B | 2.90B | 1.77B | 1.25B | -818.00M |
| Operating Cash Flow | 4.38B | 3.78B | 2.48B | 1.85B | -259.00M |
| Investing Cash Flow | -905.00M | -831.00M | -726.00M | 826.00M | -428.00M |
| Financing Cash Flow | -2.83B | -1.05B | -549.00M | -2.87B | -88.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £22.03B | 21.12 | 18.88% | 1.71% | -3.66% | -9.01% | |
76 Outperform | £112.37B | 19.21 | 604.85% | 0.91% | 9.62% | 146.74% | |
71 Outperform | £61.59B | 30.70 | 17.90% | 1.99% | 11.60% | 8.03% | |
68 Neutral | £6.73B | 23.72 | 46.10% | 0.56% | 7.36% | 48.93% | |
66 Neutral | £8.56B | 32.04 | 12.85% | 1.93% | -6.93% | 18.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £7.09B | 19.45 | 10.69% | 1.10% | -0.38% | ― |